CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,577,532 | -44.3% | 2,114,519 | -64.1% | 0.01% | -44.4% |
| Q3 2022 | $11,798,787 | -29.4% | 5,889,912 | +71.8% | 0.01% | -25.0% |
| Q2 2022 | $16,722,000 | -66.8% | 3,428,520 | -39.0% | 0.01% | -50.0% |
| Q1 2022 | $50,406,000 | -20.2% | 5,617,819 | -2.2% | 0.02% | -7.7% |
| Q4 2021 | $63,137,000 | -30.9% | 5,743,397 | +2.4% | 0.03% | -35.0% |
| Q3 2021 | $91,362,000 | -23.9% | 5,607,302 | -1.3% | 0.04% | -21.6% |
| Q2 2021 | $120,122,000 | – | 5,680,933 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $89,357,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $179,070,000 | 48.51% |
| Vida Ventures Advisors, LLC | 3,931,818 | $35,268,000 | 20.51% |
| OUP Management Co., LLC | 2,937,615 | $26,350,000 | 20.06% |
| Samsara BioCapital, LLC | 1,884,096 | $16,900,000 | 4.26% |
| Kynam Capital Management, LP | 669,100 | $6,002,000 | 1.95% |
| Cormorant Asset Management, LP | 2,489,894 | $22,334,000 | 1.72% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $86,846,000 | 0.79% |
| RA Capital Management | 3,577,094 | $32,087,000 | 0.70% |
| BVF INC/IL | 1,755,545 | $15,747,000 | 0.63% |